What throwing does to elbow cartilage

Every time a baseball pitcher releases the ball, the outer elbow absorbs a sharp compressive force as the forearm snaps through. At the same moment, a valgus torque — the arm bending outward at the elbow — loads the lateral compartment hard. Repeat that pattern across hundreds of pitches per week over months and years, and the cartilage covering the rounded end of the upper arm bone (the humeral capitellum) begins to break down in a way that has little in common with the gradual joint-space narrowing seen in older adults with osteoarthritis.

The clinical label for this injury is osteochondritis dissecans (OCD) of the capitellum — a localised area where repeated compression disrupts the cartilage and the bone beneath it, sometimes causing a fragment to loosen or detach. It is a site-specific problem of the lateral elbow compartment, affecting younger athletes whose joints are still developing rather than wearing out with age.

Gymnasts experience the same process, though the dominant load is axial compression through a weight-bearing wrist rather than a throwing arm. The two sports produce slightly different lesion locations — baseball players tend to develop damage at the front (anterior) surface of the capitellum, while gymnasts see more centrally placed lesions — but lesion size, stability, and the rate of associated complications are similar across both groups. That parity matters: the options described in the sections that follow apply broadly, regardless of which sport brought a patient to clinic.

Understanding the mechanism is not merely academic. Because the damage is driven by cumulative load rather than a single traumatic event, decisions about rest timing and how quickly throwing resumes are woven into every stage of management.

What your MRI shows and where it falls short

An MRI result is usually what brings a patient to this conversation — and it carries real information. The scan is genuinely good at measuring how much cartilage is involved: in a 2025 study comparing MRI measurements against direct intraoperative findings, lesion size on imaging correlated strongly with what surgeons observed at the time of the procedure (r=0.81, p<0.001). MRI also reliably flags features that raise clinical concern, particularly lesions that are larger in area or that extend to involve the lateral wall of the capitellum — both associated with instability and a more demanding recovery.

Where MRI falls short is on the question that matters most for treatment planning: whether the lesion is stable or unstable. In the same study, the correlation between MRI findings and true lesion stability was essentially zero (r=−0.088, p=0.696). The scan can show that damage is present and give a rough sense of its extent, but it cannot determine whether a fragment is still anchored to the underlying bone or at risk of detaching. Stability is one of the primary variables in the treatment decision, and MRI simply cannot answer it.

That gap is why some patients require arthroscopy — a camera-guided look inside the joint — before a definitive plan can be set. This is not an escalation; it is the appropriate diagnostic tool for that specific question.

A substantial-looking MRI report does not automatically lead to complex surgery, and a reassuring one does not guarantee a straightforward path. The scan is one input into a clinical picture that also draws on symptoms, examination findings, and the demands of the athlete's sport.

Is joint preservation realistic?

The good news is direct: for most throwing athletes with capitellar OCD, the joint can be preserved. Replacement is not on the standard pathway for this condition, and clinicians approach it with a preservation-first default regardless of how severe the lesion first appears on imaging.

Three variables determine which preservation route is appropriate: whether the lesion is stable or unstable, how large the affected area is, and whether damage has reached the lateral wall of the capitellum. These do not operate as a rigid checklist — they interact, and the combination matters. A useful example: a lesion that is large but still stable, with the lateral wall clear, may remain a candidate for conservative management — rest, activity modification, and supervised physiotherapy — because the cartilage surface has not broken down and there is no imminent detachment risk. Add confirmed instability at arthroscopy to that same picture, or find that the lateral wall is involved, and the clinical calculus shifts meaningfully toward earlier surgical intervention.

Stable lesions with an intact articular surface carry the widest range of options. Unstable lesions, particularly larger ones or those involving the lateral wall, generally require a more active response — but even then, the aim is repair rather than replacement.

One further point is worth holding early: a detached fragment does not automatically close the preservation window. Fragment fixation — reattaching viable bone and cartilage back to its native bed — remains an option when the fragment is still in recoverable condition. Not every loose body means the opportunity for joint preservation has passed.

Trying conservative management first

Reaching the surgical options is not inevitable. For stable capitellar OCD lesions with an intact articular surface, non-operative management is the appropriate starting point — and a genuine clinical choice, not a holding measure while the clock runs down.

In practice, conservative management means three things running in parallel: complete cessation of throwing or weight-bearing activity that loads the affected compartment; a supervised physiotherapy programme aimed at restoring movement and strengthening the surrounding musculature; and anti-inflammatory support, typically NSAIDs, to manage pain and reduce reactive swelling. The structured combination of these — rather than unguided rest alone — is what gives the joint its best chance to stabilise and for natural healing processes to progress.

The trial period typically runs for up to six months. If symptoms settle and function returns, surgery may never be required. If symptoms persist or worsen despite a genuine effort over that period, the case for intervention is reassessed.

The non-operative window narrows significantly when a lesion is confirmed as unstable, when mechanical symptoms such as locking are present, or when loose bodies are identified on imaging or examination. In those situations, deferring specialist review is unlikely to serve the athlete well.

Procedural and surgical options when conservative management is not enough

Several procedural routes are available once conservative management has been exhausted or a lesion has been confirmed as unstable at arthroscopy. They form a rough hierarchy from least to most invasive, and the appropriate level depends on lesion size, stability, and the athlete's individual anatomy.

Arthroscopic debridement with microfracture is typically the first surgical step for smaller defects. The damaged cartilage is cleared and the subchondral bone is perforated at approximately 2 mm intervals, prompting recruitment of marrow-derived cells that fill the defect with fibrocartilage. The technique is well established and minimally invasive, but it produces fibrocartilage rather than hyaline cartilage — a meaningful functional distinction — and the supporting evidence consists largely of level IV case series rather than randomised trials.

Injectable collagen scaffold (ChondroFiller injection, delivered as an ultrasound-guided outpatient procedure) is a minimally invasive option suited to appropriately sized focal defects. The acellular scaffold gels within the lesion and supports matrix-induced chondrogenesis, recruiting the patient's own progenitor cells without requiring a donor harvest or a theatre setting. Evidence specific to the elbow is early-stage; as with microfracture, this is best framed as a developing option at this joint rather than one with long-term elbow-specific trial data.

Osteochondral autograft transplantation (OAT/OATS) carries the strongest published evidence for large, unstable lesions. A 2024 systematic review of 470 patients across 24 studies found a 97% overall return-to-sport rate, with 87% of returning athletes achieving excellent functional scores. Return to the prior level of performance varied widely — from 10% to 100% across studies — and lateral lesion location was identified as the main negative predictor of outcome.

Osteochondral allograft is the preferred alternative when the defect is too large for a same-patient harvest or when donor-site morbidity is a concern.

Biological adjuncts such as PRP and BMAC are sometimes discussed in broader cartilage-repair contexts, but they have no established evidence base for elbow OCD at present and should not be considered routine additions to any of the above approaches.

No single option suits every lesion. The final choice rests on a specialist assessment of the full picture — lesion dimensions, stability as confirmed at arthroscopy, and the athlete's individual goals and timeline.

Getting back to throwing and what to expect

Returning to throwing at the previous level is the goal for most athletes — but the published evidence is candid that it is not a certainty. Return-to-sport rates after surgical treatment are generally high, yet the proportion who return to their prior competitive standard varied from 10% to 100% across OAT studies, with lateral lesion location identified as the main negative predictor of outcome.

Recovery progression should be criteria-based rather than calendar-based. Functional milestones, symmetry testing, and graded load reintroduction — not fixed weeks — are what guide safe return to throwing. Rushing that progression before the criteria are met is one of the more reliable routes to re-injury.

The overall surgical revision rate across intervention types is approximately 11% — 55 of 477 elbows in a 2025 systematic review — which means primary treatment holds for the substantial majority. That figure offers reasonable reassurance, but it also reflects a real minority who face re-operation or subsequent throwing-related injuries; even in a closely supervised cohort of 20 adolescent baseball players, two required further surgery and three sustained subsequent throwing injuries. This possibility deserves honest pre-treatment discussion rather than a footnote.

A specialist assessment at the London Cartilage Clinic on Harley Street can map the full pathway — including whether a ChondroFiller injection is appropriate for the defect profile — and appointments can be made at londoncartilage.com. The overarching aim, whichever route is chosen, is an elbow that can absorb the demands of throwing again at a level as close to baseline as the biology permits.

1. [1] The role of MRI in elbow osteochondritis dissecans: correlations with intraoperative findings and implications for clinical management. (2025). https://doi.org/10.1080/15438627.2025.2487904 https://doi.org/10.1080/15438627.2025.2487904
2. [2] A Current Methods Comparison: Treating OCD Lesions of the Capitellum With Osteochondral Autograft and Allograft Transplantation. (2023). https://doi.org/10.1016/j.jhsa.2023.08.012 https://doi.org/10.1016/j.jhsa.2023.08.012
3. [3] Are Elbow Osteochondritis Dissecans Lesions Different for Gymnasts and Baseball Players?. (2025). https://doi.org/10.1097/JSM.0000000000001336 https://doi.org/10.1097/JSM.0000000000001336
4. [4] Outcomes and return to sport after osteochondral autograft transplantation for osteochondritis dissecans of the capitellum: a systematic review. (2024). https://doi.org/10.1016/j.xrrt.2024.02.011 https://doi.org/10.1016/j.xrrt.2024.02.011
5. [5] Revision rate after surgery for elbow osteochondritis dissecans: a systematic review. (2025). https://doi.org/10.1186/s13018-025-05788-y https://doi.org/10.1186/s13018-025-05788-y
6. [6] Osteochondritis Dissecans of the Capitellum: Arthroscopic Microfracture. (2026). https://doi.org/10.1177/26350254251388504 https://doi.org/10.1177/26350254251388504
7. [7] Return to Play Rates Following Arthroscopic Treatment of Elbow Osteochondritis Dissecans Lesions in Adolescent Baseball Players. (2021). https://doi.org/10.1177/2325967121s00201 https://doi.org/10.1177/2325967121s00201
8. [8] Return to Sport and Clinical Outcomes Following Osteochondral Autograft Transplantation in Baseball Players and Gymnasts With Unstable Osteochondritis Dissecans: A Critically Appraised Topic. (2023). https://doi.org/10.1123/jsr.2022-0446 https://doi.org/10.1123/jsr.2022-0446
9. [9] Elbow Arthroscopy for Treatment of Osteochondritis Dissecans of the Capitellum. (2025). https://doi.org/10.1177/26350254251334654 https://doi.org/10.1177/26350254251334654
10. [10] Proxy for the surgery for elbow osteochondritis dissecans in adolescent baseball players. (2025). https://doi.org/10.1016/j.jseint.2025.101424 https://doi.org/10.1016/j.jseint.2025.101424